文献速递慢阻肺肺结节与肺癌

社区肺癌筛查中肺功能检查可高比例检出未诊断COPD的气流阻塞

Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
PubMed 文献 · Thorax · 2020-05-22

在曼彻斯特三个贫困地区社区肺癌筛查中纳入肺功能检查,2525名55-74岁曾吸烟者中99.4%成功完成。37.4%存在气流阻塞(FEV1/FVC<0.7),其中49.7%既往无COPD诊断,且53.3%的无既往诊断者存在症状。既往COPD诊断的气流阻塞者肺癌筛查检出率更高(adjOR 2.80)。

要点

  • 社区肺癌筛查中肺功能检查可行性高,99.4%参与者成功完成。
  • 37.4%参与者存在气流阻塞,其中近半数既往无COPD诊断。
  • 既往COPD诊断的气流阻塞者肺癌筛查检出率显著更高。

核心结论

  • 将肺功能检查纳入社区肺癌筛查项目可行,并能检出大量既往未诊断COPD的气流阻塞个体。

研究设计与样本

  • 在曼彻斯特三个贫困地区邀请55-74岁曾吸烟者参加社区肺健康检查,纳入肺功能检查、肺癌风险预测(PLCOM2012)、症状评估和戒烟建议。
  • 高风险者(PLCOM2012≥1.51%)接受两轮年度低剂量CT筛查,并检索初级保健数据库获取既往COPD诊断。

主要发现

  • 99.4%(n=2525)的参与者成功完成肺功能检查,平均年龄64.1±5.5岁,51%为女性,35%为当前吸烟者。
  • 37.4%(n=944)存在气流阻塞(FEV1/FVC<0.7),其中49.7%(n=469)既往无COPD诊断。
  • 无既往诊断者中53.3%(250/469)有症状。
  • 多因素分析显示无既往COPD诊断的气流阻塞检出与男性(adjOR 1.84,95%CI 1.37-2.47;p<0.0001)、较年轻年龄(p=0.015)、较短吸烟年限(p<0.0001)、较少每日吸烟支数(p=0.035)、较高FEV1/FVC比值(p<0.0001)及无症状(adjOR 4.19,95%CI 2.95-5.95;p<0.0001)相关。
  • 有既往COPD诊断的气流阻塞者肺癌筛查检出率显著更高(adjOR 2.80,95%CI 1.60-8.42;p=0.002)。

关键数值与推荐

  • 气流阻塞定义为FEV1/FVC<0.7。
  • 肺癌高风险定义为PLCOM2012≥1.51%,符合者接受两轮年度低剂量CT筛查。

临床怎么用

  • 在社区肺癌筛查中可同步进行肺功能检查,以发现未诊断的气流阻塞。
  • 对于有既往COPD诊断的气流阻塞者,应关注其更高的肺癌筛查检出风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD is a major cause of morbidity and mortality in populations eligible for lung cancer screening. We investigated the role of spirometry in a community-based lung cancer screening programme. METHODS: Ever smokers, age 55-74, resident in three deprived areas of Manchester were invited to a 'Lung Health Check' (LHC) based in convenient community locations. Spirometry was incorporated into the LHCs alongside lung cancer risk estimation (Prostate, Lung, Colorectal and Ovarian Study Risk Prediction Model, 2012 version (PLCOM2012)), symptom assessment and smoking cessation advice. Those at high risk of lung cancer (PLCOM2012 ≥1.51%) were eligible for annual low-dose CT screening over two screening rounds. Airflow obstruction was defined as FEV1/FVC<0.7. Primary care databases were searched for any prior diagnosis of COPD. RESULTS: 99.4% (n=2525) of LHC attendees successfully performed spirometry; mean age was 64.1±5.5, 51% were women, 35% were current smokers. 37.4% (n=944) had airflow obstruction of which 49.7% (n=469) had no previous diagnosis of COPD. 53.3% of those without a prior diagnosis were symptomatic (n=250/469). After multivariate analysis, the detection of airflow obstruction without a prior COPD diagnosis was associated with male sex (adjOR 1.84, 95% CI 1.37 to 2.47; p<0.0001), younger age (p=0.015), lower smoking duration (p<0.0001), fewer cigarettes per day (p=0.035), higher FEV1/FVC ratio (<0.0001) and being asymptomatic (adjOR 4.19, 95% CI 2.95 to 5.95; p<0.0001). The likelihood of screen detected lung cancer was significantly greater in those with evidence of airflow obstruction who had a previous diagnosis of COPD (adjOR 2.80, 95% CI 1.60 to 8.42; p=0.002). CONCLUSIONS: Incorporating spirometry into a community-based targeted lung cancer screening programme is feasible and identifies a significant number of individuals with airflow obstruction who do not have a prior diagnosis of COPD.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Balata H, Harvey J, Barber PV, et al. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD. Thorax. 2020. PMID: 32444437. doi:10.1136/thoraxjnl-2019-213584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。